Finance

Lists
Why is NKTR down ၃.၁၂%?
Dive Deeper
NKTR:NASDAQ
Nektar Therapeutics
၄၂.၂၂ US$
-၃.၁၂%
(-၁.၃၆) 1D
၄၂.၂၂ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၅, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NKTR...
Open
၄၃.၅၀ US$
High
၄၃.၅၀ US$
Low
၄၁.၃၅ US$
Mkt. cap
၁၄၄.၁၅ ဋေ
Avg. vol.
၁.၃၈ သန်း
Volume
၀.၀၀
52-wk high
၁၀၉.၀၀ US$
52-wk low
၃၃.၄၀ US$
EPS
-၆.၆၉ US$
Beta
၁.၂၆
Shares outstanding
၃.၄၁ ကုဋေ
No. of employees
၆၃
Open
၄၃.၅၀ US$
High
၄၃.၅၀ US$
Low
၄၁.၃၅ US$
Mkt. cap
၁၄၄.၁၅ ဋေ
Avg. vol.
၁.၃၈ သန်း
Volume
၀.၀၀
52-wk high
၁၀၉.၀၀ US$
52-wk low
၃၃.၄၀ US$
EPS
-၆.၆၉ US$
Beta
၁.၂၆
Shares outstanding
၃.၄၁ ကုဋေ
No. of employees
၆၃
News stories
From web sources and news partners
Investing.com UK
Investing.com UK
·
ပြီးခဲ့သည့် ၁၈ နာရီ
Nektar Therapeutics stock analysis: oversold technicals meet binary clinical risk
About Nektar Therapeutics
CEO-
Employees၆၃
Founded၁၉၉၀
Headquartersဆန်ဖရန်စစ္စကိုမြို့, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitenektar.com
Analyst ratings
Based on 11 analysts giving stock ratings to NKTR in the past 3 months
Strong buy
Buy
9
Hold
2
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for NKTR in the last 3 months.
Highest
Current ၄၂.၂၂ US$
၁၉၂.၀၀ US$ (+၃၅၄.၇၆%)
Average
၁၄၁.၅၆ US$ (+၂၃၅.၂၉%)
Lowest
၅၀.၀၀ US$ (+၁၈.၄၃%)
Analyst
Recommendation
Action
Price target
Projected
Date
Samantha Semenkow
Citi
Buy
Reiterated
၁၅၁.၀၀ US$
+၂၅၇.၇%
10/05/2026
Unknown Analyst
B. Riley Securities
Buy
Maintained
၁၅၀.၀၀ US$
+၂၅၅.၃%
10/02/2026
Roger Song
Jefferies
Buy
Maintained
၁၅၀.၀၀ US$
+၂၅၅.၃%
10/01/2026
Andy Hsieh
William Blair
Buy
Maintained
-
-
10/01/2026
Arthur He CFA
H.C. Wainwright
Buy
Maintained
၁၈၅.၀၀ US$
+၃၃၈.၂%
10/02/2026
Julian Harrison
BTIG
Buy
Maintained
၁၇၈.၀၀ US$
+၃၂၁.၆%
09/29/2026
Edward Nash
Canaccord Genuity
Buy
Maintained
၁၅၃.၀၀ US$
+၂၆၂.၄%
09/28/2026
Martin Fan
Wedbush
Hold
Reiterated
၅၀.၀၀ US$
+၁၈.၄%
09/23/2026
Jessica Fye
J.P. Morgan
Hold
Initiated
၆၅.၀၀ US$
+၅၄%
08/21/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
၁၉၂.၀၀ US$
+၃၅၄.၈%
08/20/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
08/13/2026
Jay Olson
Oppenheimer
Buy
Maintained
၁၄၀.၀၀ US$
+၂၃၁.၆%
05/08/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
၁၅၀.၀၀ US$
+၂၅၅.၃%
02/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁.၁၈ ကုဋေ
၂.၁၈ ကုဋေ
၁.၀၉ ကုဋေ
၁.၀၁ ကုဋေ
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၂.၇၃ ကုဋေ
၂.၉၇ ကုဋေ
၃.၅၇ ကုဋေ
၃.၉၁ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၆၁ ကုဋေ
၁.၁၂ ကုဋေ
၁.၃၄ ကုဋေ
၁.၂၈ ကုဋေ
Operating expense
၄.၃၃ ကုဋေ
၄.၀၉ ကုဋေ
၄.၉၁ ကုဋေ
၅.၁၉ ကုဋေ
Total operating expenses
၄.၃၃ ကုဋေ
၄.၀၉ ကုဋေ
၄.၉၁ ကုဋေ
၅.၁၉ ကုဋေ
Operating income
-၃.၁၅ ကုဋေ
-၁.၉၁ ကုဋေ
-၃.၈၃ ကုဋေ
-၄.၁၈ ကုဋေ
Other non operating income
-၁.၂၁ သိန်း
-၄.၄၀ သောင်း
-၃.၃၆ သိန်း
-၁.၀၀ သိန်း
EBT including unusual items
-၃.၅၆ ကုဋေ
-၃.၆၀ ကုဋေ
-၄.၄၈ ကုဋေ
-၄.၀၆ ကုဋေ
EBT excluding unusual items
-၃.၅၄ ကုဋေ
-၂.၇၅ ကုဋေ
-၄.၄၀ ကုဋေ
-၄.၀၀ ကုဋေ
Income tax expense
-၃.၃၀ သောင်း
၃.၁၀ သောင်း
၆.၄၀ သောင်း
၂.၀၀ ထောင်
Effective tax rate
၀.၀၉%
-၀.၀၉%
-၀.၁၄%
-
Other operating expenses
-
-
-
-
Net income
-၃.၅၅ ကုဋေ
-၃.၆၁ ကုဋေ
-၄.၄၉ ကုဋေ
-၄.၀၆ ကုဋေ
Net profit margin
-၃၀၁.၂၉%
-၁၆၅.၄၅%
-၄၁၃.၄၄%
-၄၀၀.၉၇%
Earnings per share
-၁.၈၇
-၁.၂၉
-၁.၇၈
-၁.၂၁
Interest and investment income
၂.၈၂ သန်း
၂.၇၈ သန်း
၄.၂၄ သန်း
၉.၃၅ သန်း
Interest expense
-၆.၀၅ သန်း
-၉.၇၇ သန်း
-၇.၉၄ သန်း
-၇.၂၁ သန်း
Net interest expenses
-၃.၂၃ သန်း
-၆.၉၉ သန်း
-၃.၇၀ သန်း
၂.၁၄ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၃.၁၃ ကုဋေ
-၁.၈၉ ကုဋေ
-၃.၈၁ ကုဋေ
-၄.၁၆ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ